Skip to main content
Yucai Wang, MD, Oncology, Rochester, MN

YucaiWangMD

Oncology Rochester, MN

Hematologic Oncology

Physician

Dr. Wang is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Wang's full profile

Already have an account?

  • Office

    200 1st St Sw
    Rochester, MN 55905
    Phone+1 507-284-2511
    Fax+1 507-266-4972

Education & Training

  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2016 - 2019
  • Rutgers Health/New Jersey Medical School
    Rutgers Health/New Jersey Medical SchoolResidency, Internal Medicine, 2013 - 2016
  • Nanjing University
    Nanjing UniversityClass of 2007

Certifications & Licensure

  • MN State Medical License
    MN State Medical License 2016 - 2025
  • NJ State Medical License
    NJ State Medical License 2014 - 2018
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • BTK and/or PLCG2 Mutations in Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Ibrutinib: Characteristics and Outcomes at the Time of Progression
    Yucai Wang, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • The Role of Imaging in Predicting Time to First Treatment and Overall Survival in Individuals with CLL-like High Count Monoclonal B-Cell Lymphocytosis
    Yucai Wang, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

  • Outcomes of stem cell transplant in patients with Richter transformation. 
    2019 ASCO Annual Meeting - 6/1/2019
  • Efficacy of frontline treatment regimens in follicular lymphoma: A network meta-analysis of phase III randomized controlled trials. 
    2019 ASCO Annual Meeting - 6/1/2019
  • Clinical Characteristics and Outcomes of Chronic Lymphocytic Leukemia Patients with Richter Transformation 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Join now to see all

Press Mentions

  • MCL: Event-Free Survival at 2 Years Bodes Well
    MCL: Event-Free Survival at 2 Years Bodes WellDecember 23rd, 2022
  • Association of Sex, Age, and Eastern Cooperative Oncology Group Performance Status with Survival Benefit of Cancer Immunotherapy in Randomized Clinical Trials
    Association of Sex, Age, and Eastern Cooperative Oncology Group Performance Status with Survival Benefit of Cancer Immunotherapy in Randomized Clinical TrialsAugust 3rd, 2020
  • Should Patients with DLBCL and Concurrent FL Be Included in Clinical Trials?
    Should Patients with DLBCL and Concurrent FL Be Included in Clinical Trials?August 8th, 2019

Professional Memberships